Companies / Anavex Life Sciences Corp.
Anavex Life Sciences Corp.
Nasdaq: AVXLCIK 1314052NEW YORK, NY
Financials
Ownership
92.7M shares outstanding · as of Feb 9, 2026
Ownership
| Institutions | 41.75% | 38,687,655 |
| Public float | 58.25% | 53,984,103 |
% of common shares outstanding (exact, from the latest cover-page filing). Institutions are quarterly 13F snapshots; insiders reflect current officers & directors.
Insiders 4
View all →| Insider | % of shares | Shares |
|---|---|---|
Boenisch SandraPFO & Treasurer | — | — |
Kellmeyer TerrieCEOInterim CEO | — | — |
Missling Christopher UCEOPresident and CEO · Director | — | — |
Paeger AxelDirector | — | — |
Institutional holders 189
View all →| Holder | Value | % of shares |
|---|---|---|
| $20.86M | 8.69% | |
| $17.90M | 5.43% | |
| $9.97M | 3.50% | |
| $6.72M | 2.36% | |
| $4.98M | 2.07% | |
| $4.37M | 0.94% | |
| $4.31M | 1.31% | |
| $3.22M | 0.97% | |
| $3.11M | 0.94% | |
| $2.74M | 0.83% |
Activity
Jun 30, 2026View all →
InsidersInstitutions
Who's accumulating and trimming this stock (13F).| Date | Actor | Action | Security | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|---|
| Q2 2026 as of | State Street Corporation 13F manager | Trim | Common stock | $-6.37M | -2.5M -56.14% | 1,922,770 2.07% of shares | medium |
| Q1 2026 as of | Two Sigma Investments, LP 13F manager | Add | Common stock | $4.89M | +1.6M +96.40% | 3,247,888 3.50% of shares | low |
| Q1 2026 as of | AQR Capital Management, LLC 13F manager | Add | Common stock | $1.86M | +607K +405.15% | 756,792 0.82% of shares | low |
| Q1 2023 as of | Barclays PLC 13F manager | Add | Common stock | $1.54M | +180K +1796.13% | 189,613 0.20% of shares | low |
| Q3 2025 as of | Nwam LLC 13F manager | Trim | Common stock | $-1.41M | -150K -14.66% | 874,283 0.94% of shares | low |
| Q2 2026 as of | BlackRock, Inc. 13F manager | Add | Common stock | $1.37M | +529K +7.04% | 8,055,628 8.69% of shares | low |
| Q4 2025 as of | Bank of America Corp /De 13F manager | Add | Common stock | $1.26M | +353K +206.75% | 524,189 0.57% of shares | low |
| Q2 2025 as of | Barclays PLC 13F manager | Add | Common stock | $1.25M | +136K +91.19% | 284,259 0.31% of shares | low |
5%+ ownership events
Schedule 13D / 13G
| Filer | Stance | % of class |
|---|---|---|
| Vanguard Group Inc | Passive13G/A | — |
Securities
via CUSIP / OpenFIGI
| Symbol | Type | CUSIP |
|---|---|---|
| AVXL | — | 032797300 |